Literature DB >> 2462944

Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells.

W E Berdel1, S Danhauser-Riedl, G Steinhauser, E F Winton.   

Abstract

We have studied the effect of recombinant human hematopoietic growth factors (interleukin-3 [rhIL-3], granulocyte-macrophage colony-stimulating factor [rhGM-CSF], and granulocyte CSF [rhG-CSF]) on the clonal growth of human colon adenocarcinoma cell lines HTB-38, CCL 187, and WiDr (CCL 218). The factors stimulated clonal growth of HTB-38 and CCL 187 in a capillary modification of the human tumor clonogenic assay in agar up to twofold. There were dose-response correlations over a range of 1 to 10,000 U/mL for rhIL-3, rhGM-CSF, and rhG-CSF. Incubation with neutralizing monoclonal antibodies abolished the stimulation of clonal growth by rhGM-CSF. The WiDr cell line was nonresponsive to rhIL-3 and rhGM-CSF. These results represent the first evidence that a variety of hematopoietic growth factors can stimulate the growth of clonogenic cells of some nonhematopoietic malignant cell lines in vitro.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2462944

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  53 in total

1.  GM-CSF at relatively high topic concentrations can significantly enhance the healing of surgically induced chronic wounds after radiotherapy.

Authors:  J O Fernberg; O Brosjö; S Friesland; G Masucci
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

2.  Pulmonary pleomorphic carcinoma producing granulocyte-macrophage colony-stimulating factor: report of a case.

Authors:  Toshinori Fukutomi; Mitsutomo Kohno; Yotaro Izumi; Masazumi Watanabe; Yuichiro Hayashi; Hiroaki Nomori
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

3.  Identification and cellular distribution of distinct proteins forming human GM-CSF receptor.

Authors:  S Chiba; K Shibuya; Y F Piao; A Tojo; N Sasaki; S Matsuki; K Miyagawa; K Miyazono; F Takaku
Journal:  Cell Regul       Date:  1990-03

4.  Laryngeal squamous cell carcinoma with ectopic production of granulocyte colony-stimulating factor and parathyroid hormone-related protein.

Authors:  Kohtaroh Tanaka; Ken-ichi Nibu
Journal:  Int J Clin Oncol       Date:  2005-06       Impact factor: 3.402

5.  Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device.

Authors:  Bee Luan Khoo; Gianluca Grenci; Ying Bena Lim; Soo Chin Lee; Jongyoon Han; Chwee Teck Lim
Journal:  Nat Protoc       Date:  2017-12-07       Impact factor: 13.491

Review 6.  Harnessing cancer immunotherapy during the unexploited immediate perioperative period.

Authors:  Pini Matzner; Elad Sandbank; Elad Neeman; Oded Zmora; Vijaya Gottumukkala; Shamgar Ben-Eliyahu
Journal:  Nat Rev Clin Oncol       Date:  2020-02-17       Impact factor: 66.675

Review 7.  Use and toxicity of the colony-stimulating factors.

Authors:  J R Schriber; R S Negrin
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

8.  Specific inhibition of interleukin 3 bioactivity by a monoclonal antibody reactive with hematopoietic progenitor cells.

Authors:  P D Emanuel; S C Peiper; Z Chen; D C Sheng; K S Zuckerman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

Review 9.  Why clinicians should be interested in interleukin-3.

Authors:  P Valent; K Geissler; C Sillaber; K Lechner; P Bettelheim
Journal:  Blut       Date:  1990-12

10.  Modulation of in vitro cell growth of human and murine urothelial tumor cell lines under the influence of interleukin-3, granulocyte-, macrophage- and granulocyte-colony-stimulating factor.

Authors:  T Block; F Schmid; B Geffken; U Treiber; R Busch; R Hartung
Journal:  Urol Res       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.